bicalutamide has been researched along with Fractures, Bone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolesar, JM; Momo, HD; Myint, ZW; Otto, DE; Wang, P; Yan, D | 1 |
| Mistry, R; Parr, NJ; Wadhwa, VK; Weston, R | 1 |
| Smith, MR | 1 |
| Fallon, MA; Goode, MJ; Smith, MR | 1 |
| Beer, TM; Garzotto, M; Janoff, DM; Mongoue-Tchokote, S; Mori, M; Peters, L; Peterson, C; Wersinger, EM | 1 |
2 review(s) available for bicalutamide and Fractures, Bone
| Article | Year |
|---|---|
Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis.
Topics: Abiraterone Acetate; Accidental Falls; Androgen Receptor Antagonists; Anilides; Antineoplastic Agents, Hormonal; Benzamides; Case-Control Studies; Fractures, Bone; Humans; Incidence; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Pyrazoles; Risk Factors; Thiohydantoins; Tosyl Compounds; Trauma Severity Indices | 2020 |
Osteoporosis during androgen deprivation therapy for prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Bone and Bones; Bone Density; Bone Neoplasms; Estrogens; Fractures, Bone; Humans; Male; Middle Aged; Nitriles; Osteoporosis; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2002 |
3 other study(ies) available for bicalutamide and Fractures, Bone
| Article | Year |
|---|---|
Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Density; Bone Diseases, Metabolic; Calcium; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Nitriles; Prospective Studies; Prostatic Neoplasms; Risk Factors; Time Factors; Tosyl Compounds; Vitamin D | 2009 |
Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Cross-Sectional Studies; Estradiol; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Male; Nitriles; Osteoblasts; Osteocalcin; Osteoclasts; Osteoporosis; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2003 |
Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer.
Topics: Adenocarcinoma; Age Factors; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Disease Progression; Disease-Free Survival; Follow-Up Studies; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Nitriles; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Tosyl Compounds; Treatment Failure | 2005 |